Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.

Blonski, Marie; Pallud, Johan; Gozé, Catherine; Mandonnet, Emmanuel; Rigau, Valérie; Bauchet, Luc; Fabbro, Michel; Beauchesne, Patrick; Baron, Marie-Hélène; Fontaine, Denys; Peruzzi, Philippe; Darlix, Amélie; Duffau, Hugues; Taillandier, Luc

Blonski, Marie; Pallud, Johan; Gozé, Catherine; Mandonnet, Emmanuel; Rigau, Valérie; Bauchet, Luc; Fabbro, Michel; Beauchesne, Patrick; Baron, Marie-Hélène; Fontaine, Denys; Peruzzi, Philippe; Darlix, Amélie; Duffau, Hugues; Taillandier, Luc.

Affiliation

Blonski M; Neuro-Oncology Unit, Nancy University Hospital, 29, Avenue du Maréchal Lattre de Tassigny, 54035, Nancy, France. blonski-marie@orange.fr

J Neurooncol ; 113(2): 267-75, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23479036

Subject(s)

Antineoplastic Agents, Alkylating/therapeutic use; Brain Neoplasms/drug therapy; Dacarbazine/analogs & derivatives; Glioma/drug therapy; Neoadjuvant Therapy; Neurosurgical Procedures; Adolescent; Adult; Aged; Biomarkers, Tumor/analysis; Brain Neoplasms/pathology; Brain Neoplasms/surgery; Combined Modality Therapy; Dacarbazine/therapeutic use; Female; Follow-Up Studies; Glioma/pathology; Glioma/surgery; Humans; Male; Middle Aged; Neoplasm Grading; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate; Temozolomide; Tumor Burden; World Health Organization; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Agents, Alkylating / Neurosurgical Procedures / Neoadjuvant Therapy / Dacarbazine / Glioma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurooncol Year: 2013 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google